KMT Hepatech Inc - Company Review
KMT Hepatech Inc - Company ReviewSummary
KMT Hepatech Inc (KMT) is a provider of in-vivo research services. The company ffers in vivo research services for hepatitis C, hepatitis B and malaria therapeutics. It also provides services for human hepatic toxicity studies and human-specific metabolism of drugs and chemicals. KMT’s services include tolerability evaluations, dose response study, combination therapy study, in vivo resistance evaluations and head-to-head comparison of different drugs. The company also provides prediction of dosage ranges for clinical trials, evaluation of preventive therapies, drug metabolism evaluation, human lipoprotein metabolism, and hepatotoxicity assessment, among others. It uses KMT mouse model with a humanized liver. The company’s model is used for drug discovery, development and pre-clinical studies. KMT is headquartered in Edmonton, Alberta, Canada.
This comprehensive company report of KMT Hepatech Inc provides you with company's businesses and operations information.
The profile contains critical company information including,
- Company Overview - A detailed description of the company's operations and business divisions.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
GlobalData is a one-stop solution for actionable insight into the pharmaceutical and medical device sectors. Together with the best team of researchers, analysts, epidemiologists and consultants, and an unmatched suite of proprietary databases, we provide high-quality, accurate and transparent insight that can help you achieve growth and increase business value.
Our valuable research and consulting solutions ensure you stay at the forefront of the industry by integrating accurate market forecasts and healthcare analytics on the latest trends and developments. Among other benefits, our informed healthcare industry perspectives have assisted businesses based across the pharmaceuticals, biotechnology and medical equipment markets in making strategic decisions that have increased the value of their products and services.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.